We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Texas Capital's (TCBI) Ratings Affirmed, Outlook Upgraded
Read MoreHide Full Article
Texas Capital Bancshares, Inc.’s (TCBI - Free Report) and its bank subsidiary, Texas Capital Bank, National Association’s ratings have been affirmed by Moody’s Investors Service, a rating arm of Moody’s Corporation (MCO - Free Report) . The outlook for both Texas Capital Bancshares and Texas Capital Bank N.A. has been changed to stable from negative.
Texas Capital Bancshares’s long-term issuer rating is Baa3 and its bank subsidiary, Texas Capital Bank N.A.’s long term and short-term deposits have been affirmed at A3/ Prime-2. Additionally, its standalone baseline credit assessment (“BCA”) is baa2.
Reason for Ratings Affirmation
Per Moody’s, Texas Capital Bancshares displays a healthy funding and liquidity profile on the back of improving capitalization and asset concentration, which supports its ratings.
The bank has progressed to diminish its exposure to the energy sector, which accounted for 29% of the company’s tangible common equity (TCE) base at year-end 2020, marking a plunge from 54% at year-end 2019. Additionally, it has succeeded in trimming its leveraged loan portfolio.
Notably, the ratings that Moody’s has assigned, take into consideration Texas Capital’s decline in commercial real estate loans, which now stand below two times the TCE threshold of Moody’s. However, the bank has a high concentration of construction lending, which was approximately the size of its TCE base at year-end of 2020.
The ratings affirmation also reflects Moody's outlook about Texas Capital's improved capitalization and liquidity position that would alleviate execution risks associated with the recent management changes. Though the bank’s growing capitalization remains below its similarly-rated peers, its Moody’s TCE ratio was 8.95% as of Sep 30, 2020, up from 8.88%, at year-end 2019.
Texas Capital’s bottom line is dependent on spread income, so it stays vulnerable on the low rate environment and its inability to curtail costs amid the need for ongoing business investments in the pandemic-induced economic disruptions. However, its funding profile gains from a low dependence on confidence-sensitive market funding due to the huge deposit base.
Additionally, Texas Capital is concentrated in single-client credit exposures and a lack of granularity in its loan portfolio that presents a potential for rapid decline in credit quality should many large credits become a concern at the same time. Nonetheless, Moody’s believes in Texas Capital’s past competence to handle such concentrations as indicated by its robust asset quality. Texas Capital's on balance sheet liquidity in 2020 advanced to 32% of tangible banking assets at year-end 2020, up from 14% at year-end 2019.
The alteration in Moody’s outlook to stable from negative reflects the rating agency’s view that Texas Capital will continue upgrading its asset quality and capitalization over the next year. Also, Moody’s assigned a stable outlook to the ratings because it is of the opinion that the company’s liquidity profile will remain stronger than it has been in the past.
What Could Lead to a Rating Upgrade?
Texas Capital's ratings could be upgraded if that bank materially improves its capitalization, demonstrates a lower asset risk appetite, and improves the granularity and size of its core deposit base.
When can Ratings be Downgraded?
Downward pressure on ratings could arise if there is a continued decline in Texas Capital’s capitalization or liquidity position that is inconsistent with Moody's current expectations. The bank should maintain Moody’s TCE ratio of 9% or more, to avoid a breach and focus on reducing asset concentrations or any strategic missteps.
Over the past year, shares of Texas Capital have gained 40.5% compared with 6.4% growth recorded by the industry it belongs to.
Recently, Moody’s affirmed the ratings for many finance companies. A couple of these are SVB Financial Group and Webster Financial Corporation (WBS - Free Report) . The outlook for both banks was affirmed at stable.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
Image: Bigstock
Texas Capital's (TCBI) Ratings Affirmed, Outlook Upgraded
Texas Capital Bancshares, Inc.’s (TCBI - Free Report) and its bank subsidiary, Texas Capital Bank, National Association’s ratings have been affirmed by Moody’s Investors Service, a rating arm of Moody’s Corporation (MCO - Free Report) . The outlook for both Texas Capital Bancshares and Texas Capital Bank N.A. has been changed to stable from negative.
Texas Capital Bancshares’s long-term issuer rating is Baa3 and its bank subsidiary, Texas Capital Bank N.A.’s long term and short-term deposits have been affirmed at A3/ Prime-2. Additionally, its standalone baseline credit assessment (“BCA”) is baa2.
Reason for Ratings Affirmation
Per Moody’s, Texas Capital Bancshares displays a healthy funding and liquidity profile on the back of improving capitalization and asset concentration, which supports its ratings.
The bank has progressed to diminish its exposure to the energy sector, which accounted for 29% of the company’s tangible common equity (TCE) base at year-end 2020, marking a plunge from 54% at year-end 2019. Additionally, it has succeeded in trimming its leveraged loan portfolio.
Notably, the ratings that Moody’s has assigned, take into consideration Texas Capital’s decline in commercial real estate loans, which now stand below two times the TCE threshold of Moody’s. However, the bank has a high concentration of construction lending, which was approximately the size of its TCE base at year-end of 2020.
The ratings affirmation also reflects Moody's outlook about Texas Capital's improved capitalization and liquidity position that would alleviate execution risks associated with the recent management changes. Though the bank’s growing capitalization remains below its similarly-rated peers, its Moody’s TCE ratio was 8.95% as of Sep 30, 2020, up from 8.88%, at year-end 2019.
Texas Capital’s bottom line is dependent on spread income, so it stays vulnerable on the low rate environment and its inability to curtail costs amid the need for ongoing business investments in the pandemic-induced economic disruptions. However, its funding profile gains from a low dependence on confidence-sensitive market funding due to the huge deposit base.
Additionally, Texas Capital is concentrated in single-client credit exposures and a lack of granularity in its loan portfolio that presents a potential for rapid decline in credit quality should many large credits become a concern at the same time. Nonetheless, Moody’s believes in Texas Capital’s past competence to handle such concentrations as indicated by its robust asset quality. Texas Capital's on balance sheet liquidity in 2020 advanced to 32% of tangible banking assets at year-end 2020, up from 14% at year-end 2019.
The alteration in Moody’s outlook to stable from negative reflects the rating agency’s view that Texas Capital will continue upgrading its asset quality and capitalization over the next year. Also, Moody’s assigned a stable outlook to the ratings because it is of the opinion that the company’s liquidity profile will remain stronger than it has been in the past.
What Could Lead to a Rating Upgrade?
Texas Capital's ratings could be upgraded if that bank materially improves its capitalization, demonstrates a lower asset risk appetite, and improves the granularity and size of its core deposit base.
When can Ratings be Downgraded?
Downward pressure on ratings could arise if there is a continued decline in Texas Capital’s capitalization or liquidity position that is inconsistent with Moody's current expectations. The bank should maintain Moody’s TCE ratio of 9% or more, to avoid a breach and focus on reducing asset concentrations or any strategic missteps.
Over the past year, shares of Texas Capital have gained 40.5% compared with 6.4% growth recorded by the industry it belongs to.
Currently, the company carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Rating Actions by Moody’s on Other Banks
Recently, Moody’s affirmed the ratings for many finance companies. A couple of these are SVB Financial Group and Webster Financial Corporation (WBS - Free Report) . The outlook for both banks was affirmed at stable.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>